Red Day Pharmaceuticals "Sodium chloride Injection of Moxisahydro hydrochloric Acid" approved for listing

Moxixa, a fourth-generation quinolone antibiotic, is known as "breathing quinolones" along with the left oxyfluoroxax (third generation) and Jimmy salsa (fourth generation), especially for streptococcus pneumoniae, which is currently highly resistantsodium chloride injection sodium hydrochloric acid is used to treat the following infections caused by sensitive bacteria in adults (-18 years of age), such as acute bacterial sinusitis, acute onset of chronic bronchitis, community-acquired pneumonia;the Guidelines for Clinical Application of Antibacterial Drugs (2015), the Guidelines for the Diagnosis and Treatment of Acquired Pneumonia in the Adult Community of China (2016), and other national authoritative guidelines, recommended pathanolas as the initial treatable drug for community-acquired pneumonia;it is reported that the product is the first domestic same variety in accordance with the new registration classification - chemicals 4 categories of declaration and approval of the varieties, its quality, efficacy and the original research drugs equivalent.